A pioneering trial has begun to assess whether a simple finger-prick blood test could offer an early diagnosis for Alzheimer’s disease, even before symptoms manifest. Experts are optimistic that this research will lead to an affordable and straightforward blood test, replacing the currently invasive diagnostic procedures.
At present, a definitive diagnosis of Alzheimer’s requires patients to undergo either a specialised brain scan or a lumbar puncture to obtain a sample of cerebrospinal fluid. Should the new blood test prove successful, it would be significantly more accessible, enabling quick and inexpensive testing within GP surgeries, thereby transforming early detection efforts.
